home / stock / nspr / nspr news

NSPR News and Press, InspireMD Inc. From 10/13/20

Stock Information
Company Name: InspireMD Inc.
Stock Symbol: NSPR
Market: NASDAQ
Website: inspiremd.com
Menu
NSPR NSPR Quote NSPR Short NSPR News NSPR Articles NSPR Message Board
Get NSPR Alerts

News, Short Squeeze, Breakout and More Instantly...
NSPR - InspireMD Announces Renowned Interventional Cardiologist Gary S. Roubin, M.D., Ph.D., to Join Board of Directors

TEL AVIV, Israel, Oct. 13, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced the addition of Gary Roubin, M.D., Ph.D., to In...
NSPR - InspireMD, Inc. Appoints Patrick Jamnik as Vice President of Business Development and Strategic Initiatives and Reports Inducement Grants Under NYSE American Company Guide §711(a)

TEL AVIV, Israel, Oct. 06, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR) (“Company”), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced the appointment of Pa...

NSPR - InspireMD Announces Christina Brennan, M.D., MBA to Serve in Advisory Role for Pivotal Study of CGuard Carotid Stent System

TEL AVIV, Israel, Sept. 10, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced the addition of Dr. Christina Brennan as a str...

NSPR - 5 Biotech Penny Stocks To Watch In September 2020

Top Biotech Penny Stocks To Watch Biotech penny stocks have evolved since 2020 began. What has mainly driven these stocks is the coronavirus pandemic. The COVID-19 outbreak has caused many hurdles that people did not expect this year. This has caused biotech companies to scramble in search o...
NSPR - InspireMD on go with study of CGuard Carotid Stent system

InspireMD (NYSEMKT: NSPR )   soars 47%  premarket after the FDA granted approval to proceed with a pivotal study of the CGuard Carotid Stent System, CARENET-III, for prevention of stroke in patients in the U.S. More news on: InspireMD, Inc., Healthcare stocks news, Stocks on the...

NSPR - InspireMD Announces Approval of Investigational Device Exemption (IDE) for Pivotal Study of CGuard Carotid Stent System

TEL AVIV, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced the U.S. Food and Drug Administration (“...

NSPR - InspireMD Announces the European Society of Cardiology 2020 "Best Poster Award" for Updated Data from the PARADIGM-EXTEND Study

TEL AVIV, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announces the award for Best ESC Congress Poster for the...
NSPR - (LD Micro) 360 Companies Set to Present this Week

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...

NSPR - InspireMD to Present at the LD Micro 500 Virtual Conference on September 3, 2020

TEL AVIV, Israel, Aug. 25, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that Marvin Slosman, President and Chief...

NSPR - InspireMD Regains Compliance with NYSE AMERICAN Listing Standards

TEL AVIV, Israel, Aug. 10, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that as of August 7, 2020, the Company h...
Previous 10 Next 10